Article info
PDFOriginal article
TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations
- Correspondence to Dr Hiroko Ohgaki, Section of Molecular Pathology, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, Lyon 69372 Cedex 08, France; ohgaki{at}iarc.fr
Citation
TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations
Publication history
- Accepted May 26, 2011
- First published June 20, 2011.
Online issue publication
August 10, 2020
Article Versions
- Previous version (10 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.